141 related articles for article (PubMed ID: 21862670)
1. DEspR T/CATAAAA-box promoter variant decreases DEspR transcription and is associated with increased BP in Sardinian males.
Glorioso N; Herrera VL; Didishvili T; Argiolas G; Troffa C; Bulla P; Bulla E; Ruiz-Opazo N
Physiol Genomics; 2011 Nov; 43(21):1219-25. PubMed ID: 21862670
[TBL] [Abstract][Full Text] [Related]
2. A functional 12T-insertion polymorphism in the ATP1A1 promoter confers decreased susceptibility to hypertension in a male Sardinian population.
Herrera VL; Pasion KA; Moran AM; Zaninello R; Ortu MF; Fresu G; Piras DA; Argiolas G; Troffa C; Glorioso V; Masala W; Glorioso N; Ruiz-Opazo N
PLoS One; 2015; 10(1):e0116724. PubMed ID: 25615575
[TBL] [Abstract][Full Text] [Related]
3. Integrated computational and experimental analysis of the neuroendocrine transcriptome in genetic hypertension identifies novel control points for the cardiometabolic syndrome.
Friese RS; Ye C; Nievergelt CM; Schork AJ; Mahapatra NR; Rao F; Napolitan PS; Waalen J; Ehret GB; Munroe PB; Schmid-Schönbein GW; Eskin E; O'Connor DT
Circ Cardiovasc Genet; 2012 Aug; 5(4):430-40. PubMed ID: 22670052
[TBL] [Abstract][Full Text] [Related]
4. A polymorphism of the renin gene rs6682082 is associated with essential hypertension risk and blood pressure levels in Korean women.
Park J; Song K; Jang Y; Kim Yoon S
Yonsei Med J; 2015 Jan; 56(1):227-34. PubMed ID: 25510769
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific effects of NLRP6/AVR and ADM loci on susceptibility to essential hypertension in a Sardinian population.
Glorioso N; Herrera VL; Didishvili T; Ortu MF; Zaninello R; Fresu G; Argiolas G; Troffa C; Ruiz-Opazo N
PLoS One; 2013; 8(10):e77562. PubMed ID: 24147025
[TBL] [Abstract][Full Text] [Related]
6. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure.
Chen Y; Wen G; Rao F; Zhang K; Wang L; Rodriguez-Flores JL; Sanchez AP; Mahata M; Taupenot L; Sun P; Mahata SK; Tayo B; Schork NJ; Ziegler MG; Hamilton BA; O'Connor DT
J Hypertens; 2010 Jan; 28(1):76-86. PubMed ID: 20009769
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y(1) Receptor NPY1R discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.
Wang L; Rao F; Zhang K; Mahata M; Rodriguez-Flores JL; Fung MM; Waalen J; Cockburn MG; Hamilton BA; Mahata SK; O'Connor DT
J Am Coll Cardiol; 2009 Sep; 54(10):944-54. PubMed ID: 19712806
[TBL] [Abstract][Full Text] [Related]
8. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives.
Sarzani R; Dessì-Fulgheri P; Salvi F; Serenelli M; Spagnolo D; Cola G; Pupita M; Giantomassi L; Rappelli A
J Hypertens; 1999 Sep; 17(9):1301-5. PubMed ID: 10489108
[TBL] [Abstract][Full Text] [Related]
9. The endothelial nitric oxide synthase -786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure.
Augeri AL; Tsongalis GJ; Van Heest JL; Maresh CM; Thompson PD; Pescatello LS
Atherosclerosis; 2009 Jun; 204(2):e28-34. PubMed ID: 19155013
[TBL] [Abstract][Full Text] [Related]
10. Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure.
Chen Y; Zhang K; Wen G; Rao F; Sanchez AP; Wang L; Rodriguez-Flores JL; Mahata M; Mahata SK; Waalen J; Ziegler MG; Hamilton BA; O'Connor DT
Am J Hypertens; 2011 Jan; 24(1):24-32. PubMed ID: 20814407
[TBL] [Abstract][Full Text] [Related]
11. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study.
Newhouse SJ; Wallace C; Dobson R; Mein C; Pembroke J; Farrall M; Clayton D; Brown M; Samani N; Dominiczak A; Connell JM; Webster J; Lathrop GM; Caulfield M; Munroe PB
Hum Mol Genet; 2005 Jul; 14(13):1805-14. PubMed ID: 15888480
[TBL] [Abstract][Full Text] [Related]
12. The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse.
Wong C; Mahapatra NR; Chitbangonsyn S; Mahboubi P; Mahata M; Mahata SK; O'Connor DT
Physiol Genomics; 2003 Jun; 14(1):83-93. PubMed ID: 12697907
[TBL] [Abstract][Full Text] [Related]
13. Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort.
Han J; Chen Y; Liu Y; Liang Y; Wang X; Liu L; Wang F; Zhang L; Zhang H; Wang H
Hypertens Res; 2012 Jul; 35(7):769-74. PubMed ID: 22592667
[TBL] [Abstract][Full Text] [Related]
14. Quantitative association between a newly identified molecular variant in the endothelin-2 gene and human essential hypertension.
Sharma P; Hingorani A; Jia H; Hopper R; Brown MJ
J Hypertens; 1999 Sep; 17(9):1281-7. PubMed ID: 10489105
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein.
Herrera VL; Steffen M; Moran AM; Tan GA; Pasion KA; Rivera K; Pappin DJ; Ruiz-Opazo N
BMC Mol Biol; 2016 Jun; 17(1):15. PubMed ID: 27301377
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension.
Schut AF; Janssen JA; Deinum J; Vergeer JM; Hofman A; Lamberts SW; Oostra BA; Pols HA; Witteman JC; van Duijn CM
Stroke; 2003 Jul; 34(7):1623-7. PubMed ID: 12791939
[TBL] [Abstract][Full Text] [Related]
17. The role of a FADS1 polymorphism in the association of fatty acid blood levels, BMI and blood pressure in young children-Analyses based on path models.
Wolters M; Dering C; Siani A; Russo P; Kaprio J; Risé P; Moreno LA; De Henauw S; Mehlig K; Veidebaum T; Molnár D; Tornaritis M; Iacoviello L; Pitsiladis Y; Galli C; Foraita R; Börnhorst C;
PLoS One; 2017; 12(7):e0181485. PubMed ID: 28732058
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y (NPY): genetic variation in the human promoter alters glucocorticoid signaling, yielding increased NPY secretion and stress responses.
Zhang K; Rao F; Miramontes-Gonzalez JP; Hightower CM; Vaught B; Chen Y; Greenwood TA; Schork AJ; Wang L; Mahata M; Stridsberg M; Khandrika S; Biswas N; Fung MM; Waalen J; Middelberg RP; Heath AC; Montgomery GW; Martin NG; Whitfield JB; Baker DG; Schork NJ; Nievergelt CM; O'Connor DT
J Am Coll Cardiol; 2012 Oct; 60(17):1678-89. PubMed ID: 23021333
[TBL] [Abstract][Full Text] [Related]
20. The -318 C>G single-nucleotide polymorphism in GNAI2 gene promoter region impairs transcriptional activity through specific binding of Sp1 transcription factor and is associated with high blood pressure in Caucasians from Italy.
Menzaghi C; Paroni G; De Bonis C; Soccio T; Marucci A; Bacci S; Trischitta V
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S115-9. PubMed ID: 16565233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
